Organogenesis Gains Special FDA Designation for ReNu Knee OA Therapy
ReNu comprises amniotic fluid cells and micronized amniotic membrane, and contains cellular, growth factor and extracellular matrix components....
ReNu comprises amniotic fluid cells and micronized amniotic membrane, and contains cellular, growth factor and extracellular matrix components....
Expanded coverage includes treatment of symptomatic full-thickness cartilage defects in the patella and multiple cartilage defects in the knee....
Locate Bio developed CognitOss resorbable antibiotic-loaded bone graft to treat osteomyelitis....
This demineralized bone fiber form is designed for minimal access delivery into expandable cages, revisions and other surgical applications....
In 1H21, the company will launch FusePure Demineralized Bone Matrix, Strips and Cubes, and FuseTrilogy Viable Bone Matrix....
The company has completed recruitment and treated all patients in its Phase III study with the viscosupplement, JTA-004, in...
Over 25,000 of Theracell's licensed demineralized bone fiber products have been delivered by the company's licensee partners....
The human extracellular matrix is slated to enter a Phase 1/2 Trial for knee cartilage regeneration in 1Q21....
FIBRI-CELL with Osteo-Spin offers a novel approach to enhance traditional bone graft substitutes for orthopedic fusion....
During its 10 years’ partnership with LAS Brasil, Graftys achieved the milestone of 10,000 units of GRAFTYS HBS sold in...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.